Information Provided By: 
Fly News Breaks for August 17, 2017
GMED
Aug 17, 2017 | 11:07 EDT
Piper Jaffray analyst Matt O'Brien says that given fear among investors that the system would not receive approval for a long time, this morning's announcement from Globus Medical that the Excelsius GPS robotics system received 510k approval is a "clear positive." The analyst adds that he continues to receive favorable commentary from clinicians about the Globus' robotic system. He recommends buying the stock at current levels.
News For GMED From the Last 2 Days
There are no results for your query GMED
